An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Bone Metastasis 80%
• Osteoclast Differentiation Factor 60%
• Bisphosphonic Acid Derivative 40%
• Cancer Growth 40%
• Pathophysiology 20%
• Biological Product 20%
• Drug Development 20%
• Bone Defect 20%

Biochemistry, Genetics and Molecular Biology

• RANKL 100%
• Cancer Cell 33%
• Homeostasis 33%
• Cell-Cell Interaction 33%
• Stromal Cell 33%
• Bone Development 33%

Keyphrases

• Anti-RANKL 75%
• Yield Factor 25%
• Basic multicellular Unit 25%
• Bone Degradation 25%